FAIRMOUNT FUNDS MANAGEMENT LLC enters CYCLERION THERAPEUTICS, INC. with 9.10M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 9/10/2026ACC: 0001193125-26-388112
Director10% Owner
Since Sep 2026
9.10M
Baseline shares
0.00
Direct ownership
0 positions
2.14M
Derivative underlying
2 instruments
2
Security positions
9.10M indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned2.19M
Common Stock
IndirectShares owned6.91M
Total
9.10M indirect9.10M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.19M | Indirect |
| Common Stock | 6.91M | Indirect |
| Total | 9.10M | 9.10M indirect |
Derivative Holdings2
Series B Non-Voting Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
2.07M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Pre-funded Warrant
IndirectUnderlying security
Common Stock
Underlying shares
66.44K
Shares owned
N/A
Exercise price
0.0001
Expiration
—
Exercise window
—
Total
Underlying
2.14M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Non-Voting Preferred Stock Indirect | Common Stock | — | — | 2.07M | N/A | |
| Pre-funded Warrant Indirect | Common Stock | 0.0001 | — | — | 66.44K | N/A |
| Total | 2.14M | 0.00 | ||||